tirzepatide discontinuation GLP-1 receptor agonists and have transformed obesity and type 2 diabetes care. But the next major challenge is becoming clear: durable metabolic maintenance. A recent Nature Reviews… semaglutide or tirzepatide side effects

GLP-1s have excelled in treating not only obesity and diabetes, but also sleep apnea, cardiovascular disease, and liver scarring

Notably, the data set lacked information on ethnicity, which is particularly significant given that previous research indicates African American race was associated with 33% higher rates of OSA

the metabolic capacity of the strain during passage through the GI tract

More of this, please

We learned that although the drugs may provide a fast-lane to weight loss, diet and exercise remain key to avoid malnutrition, minimize side effects, and keep your bones and muscles strong

doi: 10.1210/clinem/dgaa863 190 LeeCJMaoHThieuVTLandLFThomasMK